{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:04:12Z","timestamp":1794535452981,"version":"4.9.1"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>The potential of psychedelics to persistently treat substance use disorders is known since the 1960s. However, the biological mechanisms responsible for their therapeutic effects have not yet been fully elucidated. While it is known that serotonergic hallucinogens induce changes in gene expression and neuroplasticity, particularly in prefrontal regions, theories on how specifically this counteracts the alterations that occur in neuronal circuitry throughout the course of addiction are largely unknown. This narrative mini-review endeavors to synthesize well-established knowledge from addiction research with findings and theories regarding the neurobiological effects of psychedelics to give an overview of the potential mechanisms that underlie the treatment of substance use disorders with classical hallucinogenic compounds and point out gaps in the current understanding.<\/jats:p>","DOI":"10.3389\/fnins.2023.1156319","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:10:02Z","timestamp":1681708202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Mini-review: The neurobiology of treating substance use disorders with classical psychedelics"],"prefix":"10.3389","volume":"17","author":[{"given":"Marvin M.","family":"Urban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz R.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus W.","family":"Meinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0074-7742(10)91009-X","article-title":"Alcohol and the prefrontal cortex","volume":"91","author":"Abernathy","year":"2010","journal-title":"Int Rev Neurobiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s41465-019-00151-6","article-title":"Can psychedelic drugs attenuate age-related changes in cognition and affect?","volume":"4","author":"Aday","year":"2020","journal-title":"J Cogn Enhance"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"108519","DOI":"10.1016\/j.neuropharm.2021.108519","article-title":"Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction","volume":"188","author":"Al\u2019Absi","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"113546","DOI":"10.1016\/j.bbr.2021.113546","article-title":"Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice","volume":"416","author":"Almeida","year":"2022","journal-title":"Behav. Brain Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2011.11.022","article-title":"Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions","volume":"72","author":"Ansell","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref9001","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/brain\/awv113","article-title":"Smaller amygdala and medial prefrontal cortex predict escalating stimulant use","volume":"138","author":"Becker","year":"2015","journal-title":"Brain"},{"key":"ref9002","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/molecules25051172","volume":"25","author":"Benko","year":"2020","journal-title":"Molecules"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/adb.12614","article-title":"DRD2 promoter methylation and measures of alcohol reward: functional activation of reward circuits and clinical severity","volume":"24","author":"Bidwell","year":"2019","journal-title":"Addict. Biol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64","author":"Bogenschutz","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiat."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2014.00068","article-title":"Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex","volume":"5","author":"Bombardi","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/cells10081902","article-title":"Serotonin heteroreceptor complexes and their integration of signals in neurons and Astroglia\u2014relevance for mental diseases","volume":"10","author":"Borroto-Escuela","year":"2021","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2013.11.104","article-title":"Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes","volume":"443","author":"Borroto-Escuela","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref16","first-page":"956","article-title":"Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells","volume":"48","author":"Boundy","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study","volume":"7","author":"Bouso","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","article-title":"Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans","volume":"25","author":"Bouso","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbr.2014.12.014","article-title":"Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites","volume":"281","author":"Buchborn","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0014-2999(85)90407-8","article-title":"Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain","volume":"109","author":"Buckholtz","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/0024-3205(88)90342-6","article-title":"Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors","volume":"42","author":"Buckholtz","year":"1988","journal-title":"Life Sci."},{"key":"ref22","first-page":"137","article-title":"Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain","volume":"3","author":"Buckholtz","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e13229","DOI":"10.1111\/adb.13229","article-title":"Classic psychedelics and alcohol use disorders: a systematic review of human and animal studies","volume":"27","author":"Calleja-Conde","year":"2022","journal-title":"Addict. Biol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/09540261.2022.2040450","article-title":"Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels","volume":"34","author":"Castaldelli-Maia","year":"2022","journal-title":"Int. Rev. Psychiatry (Abingdon, England)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fphar.2014.00228","article-title":"Adolescent cocaine exposure simplifies orbitofrontal cortical dendritic arbors","volume":"5","author":"DePoy","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref9011","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14737175.2016.122083","article-title":"Psilocybin for treating substance use disorders?","volume":"17","author":"de Veen","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review","volume":"47","author":"DiVito","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.56","article-title":"In vivo imaging of cerebral serotonin transporter and Serotonin2A receptor binding in 3,4-Methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d) and hallucinogen users","volume":"68","author":"Erritzoe","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s0361-9230(97)00384-5","article-title":"The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41","volume":"45","author":"Feldman","year":"1998","journal-title":"Brain Res. Bull."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.biopsych.2007.07.009","article-title":"Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder","volume":"63","author":"Frokjaer","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fpsyt.2019.00943","article-title":"Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials","volume":"10","author":"Fuentes","year":"2020","journal-title":"Front. Psych."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jphysparis.2013.05.001","article-title":"Prefrontal cortex and neural mechanisms of executive function","volume":"107","author":"Funahashi","year":"2013","journal-title":"J. Physiol. Paris"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","article-title":"Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications","volume":"12","author":"Goldstein","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/sj.npp.1300711","article-title":"Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex","volume":"30","author":"Gresch","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","article-title":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpsychires.2016.08.006","article-title":"Behavioral impulsivity mediates the relationship between decreased frontal gray matter volume and harmful alcohol drinking: a voxel-based morphometry study","volume":"83","author":"Gr\u00f6pper","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"ref39","first-page":"421","volume-title":"Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907","author":"Hall","year":"2000"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0028-3908(01)00166-6","article-title":"Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT2A receptor mediation of the HPA axis","volume":"42","author":"Hemrick-Luecke","year":"2002","journal-title":"Neuropharmacology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J Psychopharmacol"},{"key":"ref9004","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/35094560","article-title":"Addiction and the brain: the neurobiology of compulsion and its persistence","volume":"2","author":"Hyman","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1523\/JNEUROSCI.21-02-00676.2001","article-title":"Amygdala regulation of nucleus Accumbens dopamine output is governed by the prefrontal cortex","volume":"21","author":"Jackson","year":"2001","journal-title":"J. Neurosci."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/npp.2010.82","article-title":"The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats","volume":"35","author":"Jin","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: a population study","volume":"29","author":"Johansen","year":"2015","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1038\/s41598-022-08085-4","article-title":"Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1523\/JNEUROSCI.6078-08.2009","article-title":"Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation","volume":"27","author":"Jourdi","year":"2009","journal-title":"J. Neurosci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.biopsych.2013.04.028","article-title":"Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric Acidergic transmission in the central amygdala in cocaine addiction","volume":"74","author":"Kallupi","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41386-022-01361-x","article-title":"Sustained effects of single doses of classical psychedelics in humans","volume":"48","author":"Knudsen","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fpsyt.2013.00072","article-title":"Addiction is a reward deficit and stress surfeit disorder","volume":"4","author":"Koob","year":"2013","journal-title":"Front. Psych."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/7854_2021_288","article-title":"Anhedonia, Hyperkatifeia, and negative reinforcement in substance use disorders","volume-title":"Anhedonia: preclinical, translational, and clinical integration","author":"Koob","year":"2022"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neubiorev.2018.09.008","article-title":"Addiction and stress: an allostatic view","volume":"106","author":"Koob","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40429-021-00401-8","article-title":"Novel treatment approaches for substance use disorders: therapeutic use of psychedelics and the role of psychotherapy","volume":"9","author":"Koslowski","year":"2022","journal-title":"Curr. Addict. Rep."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nicl.2015.08.009","article-title":"The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity","volume":"11","author":"Kraehenmann","year":"2016","journal-title":"NeuroImage"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref570","doi-asserted-by":"publisher","DOI":"10.1177\/00221678211048049","article-title":"Classic psychedelic use and mechanisms of mental health: exploring the mediating roles of spirituality and emotion processing on symptoms of anxiety, depressed mood, and disordered eating in a community sample","author":"Lafrance","year":"2021","journal-title":"J. Humanist. Psychol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.neuroimage.2012.05.044","article-title":"Amygdala-prefrontal coupling underlies individual differences in emotion regulation","volume":"62","author":"Lee","year":"2012","journal-title":"NeuroImage"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.neubiorev.2007.10.003","article-title":"Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal\u2013limbic dysfunction in psycho-stimulant addiction","volume":"32","author":"Li","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/02791072.2012.704590","article-title":"Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions","volume":"44","author":"Liester","year":"2012","journal-title":"J. Psychoactive Drugs"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addiction--a clinical perspective","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1046\/j.1365-2826.2002.00861.x","article-title":"Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis","volume":"14","author":"Lowry","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41380-021-01159-1","article-title":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","volume":"26","author":"Lu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","article-title":"Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling","volume":"69","author":"L\u00fcscher","year":"2011","journal-title":"Neuron"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","article-title":"Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth","volume":"4","author":"Ly","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1176\/appi.ajp.2018.17040415","article-title":"Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects","volume":"176","author":"Mackey","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1523\/JNEUROSCI.4062-12.2013","article-title":"Rescue of Infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence","volume":"33","author":"Meinhardt","year":"2013","journal-title":"J. Neurosci."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci. Adv."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.addicn.2022.100025","article-title":"Classic and non-classic psychedelics for substance use disorder: a review of their historic, past and current research","volume":"3","author":"Mendes","year":"2022","journal-title":"Addict Neurosci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1055\/a-1341-1907","article-title":"Classical psychedelics as therapeutics in psychiatry - current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders","volume":"54","author":"Mertens","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"ref9007","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuropharm.2013.10.021","article-title":"Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action","volume":"79","author":"Mocci","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2004.07.044","article-title":"Lysergic acid diethylamide and [\u2212]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex","volume":"1023","author":"Muschamp","year":"2004","journal-title":"Brain Res."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am. J. Addict."},{"key":"ref76","first-page":"959","article-title":"Chapter 49 \u2013 classic psychedelics as therapeutics for psychiatric disorders","volume-title":"Handbook of behavioral neuroscience","author":"Nichols","year":"2020"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging New paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"109257","DOI":"10.1016\/j.neuropharm.2022.109257","article-title":"Psychedelics therapeutics: what we know, what we think, and what we need to research","volume":"223","author":"Nutt","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41386-022-01324-2","article-title":"Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice","volume":"47","author":"P\u0119dzich","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.npp.1300819","article-title":"Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress-and drug-induced dopamine release in the rat medial prefrontal cortex","volume":"31","author":"Pehek","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/0004867421998785","article-title":"Medicinal psychedelics for mental health and addiction: advancing research of an emerging paradigm","volume":"55","author":"Perkins","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0006-8993(94)90495-2","article-title":"Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro","volume":"654","author":"Pessia","year":"1994","journal-title":"Brain Res."},{"key":"ref9008","doi-asserted-by":"publisher","DOI":"10.1177\/26331055211033847","article-title":"Engineering Safer Psychedelics for Treating Addiction","volume":"16","author":"Peters","year":"2021","journal-title":"Neurosci. Insights"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cereb Cortex"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neulet.2018.10.018","article-title":"Downregulation of mGluR2\/3 receptors during morphine withdrawal in rats impairs mGluR2\/3-and NMDA receptor-dependent long-term depression in the nucleus accumbens","volume":"690","author":"Qian","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2013.01.019","article-title":"The impulsivity behavior is correlated with prefrontal cortex gray matter volume reduction in heroin-dependent individuals","volume":"538","author":"Qiu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"E835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2016.02.029","article-title":"Extended amygdala to ventral tegmental area Corticotropin-releasing factor circuit controls binge ethanol intake","volume":"81","author":"Rinker","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn3111","article-title":"Transcriptional and epigenetic mechanisms of addiction","volume":"12","author":"Robison","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jpsychires.2021.03.002","article-title":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review","volume":"137","author":"Romeo","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.biopsych.2010.03.013","article-title":"Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients","volume":"67","author":"Rosell","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.psc.2012.04.002","article-title":"Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies","volume":"35","author":"Ross","year":"2012","journal-title":"Psychiatr. Clin. North Am."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/00952990.2014.933840","article-title":"Molecular neurobiology of addiction: what\u2019s all the (\u0394)FosB about?","volume":"40","author":"Ruffle","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0165-0173(00)00024-2","article-title":"Stress-induced relapse to heroin and cocaine seeking in rats: a review","volume":"33","author":"Shaham","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e1194","DOI":"10.1038\/tp.2017.161","article-title":"Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction","volume":"7","author":"Sharp","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.neuroscience.2008.11.036","article-title":"Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A","volume":"158","author":"Shelton","year":"2009","journal-title":"Neuroscience"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.neuropharm.2008.06.001","article-title":"Sustained treatment with a 5-HT2A receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT2A receptors despite increases in receptor protein levels in rats","volume":"55","author":"Shi","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1038\/tp.2012.11","article-title":"Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability","volume":"2","author":"Shumay","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1152\/physrev.00013.2008","article-title":"Alcoholism: a systems approach from molecular physiology to addictive behavior","volume":"89","author":"Spanagel","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuropharm.2013.05.046","article-title":"Amygdala and bed nucleus of the stria terminalis circuitry: implications for addiction-related behaviors","volume":"76","author":"Stamatakis","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1176\/jnp.23.2.jnp121","article-title":"Anterior cingulate cortex: unique role in cognition and emotion","volume":"23","author":"Stevens","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref9009","doi-asserted-by":"publisher","first-page":"9760","DOI":"10.1523\/JNEUROSCI.1427-04.2004","article-title":"Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites","volume":"24","author":"Takei","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/02698811211008554","article-title":"Psychedelics and health behaviour change","volume":"36","author":"Teixeira","year":"2022","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"ref9010","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0269881118771782","article-title":"Psychedelic use and intimate partner violence: The role of emotion regulation","volume":"32","author":"Thiessen","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref104","first-page":"157","article-title":"Chapter seven \u2013 treating addiction: perspectives from EEG and imaging studies on psychedelics","volume-title":"International review of neurobiology","author":"T\u00f3foli","year":"2016"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1134454","DOI":"10.3389\/fpsyt.2023.1134454","article-title":"Therapeutic effect of psilocybin in addiction: a systematic review","volume":"14","author":"van der Meer","year":"2023","journal-title":"Front. Psych."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review","volume":"140","author":"van Elk","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in drug abuse and addiction: results of imaging studies and treatment implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1176\/ajp.152.4.613","article-title":"Effect of naltrexone on alcohol high in alcoholics","volume":"152","author":"Volpicelli","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13556210500222670","article-title":"How does bupropion work as a smoking cessation aid?","volume":"10","author":"Warner","year":"2005","journal-title":"Addict. Biol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.ajp.2015.15060710","article-title":"Neural circuitry of impaired emotion regulation in substance use disorders","volume":"173","author":"Wilcox","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/7854_2009_27","article-title":"Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse","volume":"3","author":"Willuhn","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrn.2016.39","article-title":"Synaptic mechanisms underlying persistent cocaine craving","volume":"17","author":"Wolf","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2015.05.030","article-title":"Regional gray matter deficits in alcohol dependence: a meta-analysis of voxel-based morphometry studies","volume":"153","author":"Xiao","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/s0006-8993(00)02080-1","article-title":"Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine","volume":"863","author":"Yan","year":"2000","journal-title":"Brain Res."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.1523\/JNEUROSCI.22-21-09635.2002","article-title":"Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (\u2212)DOI","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1156319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:10:07Z","timestamp":1681708207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1156319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":126,"alternative-id":["10.3389\/fnins.2023.1156319"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1156319","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1156319"}}